TriAltus Bioscience is transforming protein-based research, making it easier and more affordable to obtain high-quality materials needed in the lab with our revolutionary CL7-tag purification system.
HIGH YIELD | HIGH PURITY | HIGH ACTIVITY
Introducing the CL-7 affinity tag system
We believe that researchers want to spend more time making discoveries in the search for new therapeutics, and less time working to produce their target proteins in the purity and quantity needed. Learn more about how our CL-7 affinity tag purification system can help.
BIRMINGHAM, Ala. – TriAltus Bioscience, LLC today announced the launch of its Activated Im7 affinity chromatography resin for the CL7/Im7 protein purification system. This new version more than doubles the single-step protein purification system’s original binding capacity from 15 – 20 mg/ml to 35 – 40 mg/ml of CL7-tagged protein. Read more.
Chinese Scientists Use TriAltus Bioscience’s CL-7 Purification System to Purify CRISPR-associated Proteins
BIRMINGHAM, Ala. (August 29, 2018)—TriAltus Bioscience, LLC today announced that scientists at Hubei University in China successfully co-expressed and purified ribonucleoprotein complexes—including Cas9 and Cas12a CRISPR-associated proteins—from E. coli in a single step using the company’s licensed CL-7 purification technology. The Hubei scientists published the results of their work in late July. “This team’s success […]
TriAltus Bioscience has been recognized by the Birmingham Business Alliance as one of its bioscience companies to watch in this growing industry sector. Read more.